Rhodococcus equi: first case in a heart transplant recipient

J Heart Lung Transplant. Mar-Apr 1994;13(2):332-5.

Abstract

Rhodococcus equi is a gram-positive diphtheroid that occasionally affects immunocompromised patients, usually causing a chronic respiratory infection with cavitating pulmonary opacities on chest radiograph that resemble mycobacterial or fungal disease. Etiologic diagnosis presents a number of pitfalls, because Rhodococcus equi isolates mimic many of the characteristics of other microorganisms more familiar to the laboratory staff. The treatment of choice for this disease has not yet been established, and its mortality rate is greater than 50% in individuals with human immunodeficiency virus and 20% to 25% among the remaining patients. We describe here the first case of Rhodococcus equi infection in a heart transplant recipient. Clinical presentation was typical, and treatment with a sensitivity-based combination of antibiotics resulted in resolution of both the clinical and radiologic picture.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents
  • Cardiomyopathies / immunology
  • Cardiomyopathies / surgery*
  • Drug Therapy, Combination / therapeutic use
  • Heart Transplantation / immunology*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Male
  • Microbial Sensitivity Tests
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / immunology*
  • Pneumonia / immunology*
  • Postoperative Complications / drug therapy
  • Postoperative Complications / immunology*
  • Rhodococcus equi / drug effects
  • Rhodococcus equi / immunology*
  • Sepsis / immunology*

Substances

  • Anti-Bacterial Agents
  • Immunosuppressive Agents